Open original FDA record ↗Recall record
- FDA identifier
- Z-1997-2013
- Company in FDA record
- Beckman Coulter Inc.
- FDA classification date
- Aug 22, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Beckman Coulter has received a customer complaint that suggests trending of positive results has increased from approximately 4% to 1 0%. As a result of our investigation, Beckman Coulter has confirmed an increase in sensitivity at the borderline positive level. " This testing also demonstrated that the issue does not affect results reported as negative.
Source facts
- Action
- Beckman Coulter sent an Urgent Product Correction letter dated July 9, 2013, to all affected customers. The letter was accompanied with a cover letter and response form, dated July 9, 2013. Customers were informed of the product under recall with product description, actions to take, contact information, the issue, impact, and resolution. Beckman Coulter conducted a risk assessment for this issue. Per the risk documentation, there is only a remote probability that use of the product will cause any adverse health consequences,and the product is not likely to lead to serious adverse health consequences. If you have any questions please call (714) 961-3777.
- Initiated
- 2013-07-17
- Root cause
- Under Investigation by firm
- Terminated
- 2014-10-24
- Distribution
- Worldwide Distribution - USA and the country of Canada.
- Recall number
- Z-1997-2013
- Recall status
- Terminated
- CDRH record ID
- 120341
- FDA classified
- 2013-08-22
- Recall event number
- 65832